Sri Lanka is a recent focus having Leishmania donovani induced cutaneous leishmaniasis (CL) as the main clinical entity. A separate clinical entity within profile of CL was described in this study. Laboratory confirmed cases of CL (n= 950, 2002-2014) were analysed. Most lesions showed known classical developmental stages of CL (CCL) observed in other CL endemic settings while few cases (13%, 122/950) showed atypical skin manifestations (ACL). Clinical, geographical, and treatment response patterns of ACL were different from those of CCL. ACL was mainly found among males (68.0%), in 21-40 year age group (51.6%), and reported delayed treatment seeking (23.5% vs 16.3% in CCL), more nonclassical onset (lesions other than acne form <1cm sized papules), (12.1 vs 2.7%, P<0.05.), more head and neck lesions (41.5%. vs 27.2%), more large lesions (>4cm), (18.6 vs 9.9%), and poor laboratory positivity rates (65.6% vs 88.2%) when compared to CCL. When compared to lesions reporting a typical onset, lesions reporting nonclassical onset were more likely to develop ACL later on (50.1% vs 10.7%). As compared to lesions on limbs, those on head and neck and trunk were more likely to be ACL (7.0%, 16.3%, and 22.8%, respectively, P<0.05). ACL features were not age or gender dependent. Highest proportion within ACL category (32.8%) and small proportion of CCL (10.1%) originated from less leishmaniasis prevalent areas (other regions) (P<0.05). North reported more ACL than South (15.9% vs 7.4%). A total of 95 CL cases with a significant travel history were further analyzed. Residents of other regions when acquired infection from North or South developed more ACL than residents in North or South (60.9% vs 15.9% and 42.9% vs 7.4% respectively). Patients in other regions when travelled to North developed more ACL than when they travelled to South (60.9%, 42.9%). ACL and CCL required an average of 18 doses over 16.7 months and 10 doses over 12 weeks, respectively, to achieve a complete clinical cure. Underlying host immunological factors, parasite strain variations and regional variations of both could be underlying etiologies. Established independent transmission within less leishmaniasis prevalent regions combined with an unusual clinical picture leading to poor clinical suspicion and low laboratory confirmation rate will pose potential difficulties in early case detection in these highly populated and commercialized areas. This in turn will further facilitate silent and high disease transmission.
Introduction
Different clinical entities in leishmaniasis (i.e., cutaneous; CL, visceral; VL and mucosal leishmaniasis; MCL) are mainly determined by the infecting species that are multiple among the genus Leishmania. CL is the commonest reported clinical form affecting many tropical and sub-tropical countries with an increasing incidence [1, 2] . Classical leishmanial ulcer develops over an exposed body area from a painless acne-form papule that enlarges and eventually ulcerate at its summit. Lesions often remain single and are known to selfheal eventually.
Visceralizing Leishmania affect internal organs and clinically apparent untreated VL is fatal.
VL is known to cause great mortality and morbidity [3] [4] [5] . Despite regional variation there is significant decrease in the number of new VL cases in South east Asian region and also some decrease in other parts of the world that has led 2 Journal of Tropical Medicine WHO to revision of the global estimates [3, [6] [7] [8] [9] [10] [11] [12] [13] , in spite of the regional drive that aims at disease elimination in Indian subcontinent by year 2020.
A genetic variant of L. donovani, the usual cause of VL, has been reported to cause a large outbreak of CL in Sri Lanka since year 2001 [14] [15] [16] . Widening dimensions of CL outbreak [17] [18] [19] , micro-changes within the continued profile of CL [20] , varied risk factors for transmission [21] , case clustering of CL in communities [22] , poor treatment response [23] , CL associated humoral response [24] and emergence of few MCL and VL cases [25] [26] [27] , and species/strain variation [28] are of recent local concern. Urgent need for disease control has been highlighted at several occasions [29, 30] . L. donovani is mainly anthroponotic in the Asian region, and reduction of human infection is considered critical in L. donovani control [1, 31] . However, nondisturbing nature of most initial skin lesions leads to poor self-referral. Absence of pathognomonic clinical features in leishmaniasis often makes the clinical diagnosis difficult. CL caused by L donovani is still rare and literature on this clinical entity is scarce [32] [33] [34] . Previous studies in Sri Lanka identified useful clinical markers for field screening and case interpretation in classical CL (CCL) [35] . Atypical manifestations of CL (ACL) were first identified in a minority during the early stages of the epidemic [18] .
ACL comprise an important category that can complicate initial clinical screening leading to late or misdiagnosis of CL. Many clinical forms including erysepeloid, zosteriform, disseminated, lupoid, and verrucous lesions have been described in association with classical CL [36] [37] [38] [39] . Genetic variation, altered immune pathological sequences, and varied treatment response have also been identified or suggested as underlying reasons for ACL [40, 41] . Understanding the early and late presentations, immediate and long-term sequelae, outcome of treated and untreated lesions, and aetiology of different clinical variants is important for patient management and disease containment. Current study aimed at describing the atypical clinical forms associated with L. donovani induced CL in Sri Lanka.
Materials and Methods
Patients investigated at the Center for research, training, and diagnosis of leishmaniasis, in University of Colombo (late 2002-early 2014), with suspected skin lesions of cutaneous leishmaniasis were recruited after informed consent. Clinical evaluation and sample collection were carried out by PI/ qualified medical officers and trained technical officers, respectively. Laboratory confirmation was established by microscopy, culture or PCR [42, 43] . Demographic, travel, and treatment data of laboratory positive cases and clinical data pertaining to a randomly selected single lesion (in single or multiple lesions) of each patient were collected. An equal number of time matched (presented within a month) cases of CCL were considered together with all laboratory confirmed cases of ACL for analysis of travel data and geographical variations. A subset of 40 patients with laboratory confirmed ACL were followed up for a period of 2 years to analyse treatment outcome. Missing and doubtful information and case histories with inadequate information were excluded on a case by case basis or lesion wise. Data analysis was carried out using SPSS. 
Results
A total of 1125 clinically suspected lesions (including 186 lesions clinically diagnosed as ACL) were considered for the analysis. Light microscopy, IVC, or PCR methods confirmed CL in 950/1125 patients. There were 12.8% (122/950) ACL cases and 87.2% (n=828/950) CCL among the laboratory confirmed patients. Laboratory confirmed group was considered for further analysis. Parasite positive rate of ACL was less as compared to that of CCL (65.6%, 122/186 vs 88.2% (n=828/939). It did not vary significantly over the course of ACL, except for a slight reduction observed in chronic lesions (60% in >1 year lesions), (data not tabulated).
Majority of patients with atypical lesions were between 21 and 40 years of age (n=63/122, 51.6%). Males were affected more than females (83/122, 68.0%). There were no gender associated differences between proportions of CCL and ACL in total population (Table 1) . However proportion of 21-40 year old cases with ACL increased significantly with lesion duration (Tables 1 and 2 . Only a few lesions reported other features at the onset (multiple acne-form papules, macular rash, discolored patchy, etc.). However, proportion of ACL started as nonclassical primary lesions was significantly higher as compared to that of CCL (12.1% vs 2.7%) ( Table 2 ). In this group, 15/31, 50% developed into atypical stages subsequently also. Almost all the lesions starting as a classical primary lesion developed in to chronic CCL later on 89.3% while only 50% of lesions starting as other types developed in to CCL (Table 2 ). However long-standing ACL lesions reported a typical onset as compared to early ACL lesions (Table 2 ).
More than a half of ACL lesions remained small (<2cm) (61/113, 54%) while 18.6% of lesions were large (>4cm).
Proportion of large ACL lesions were higher as compared to that of CCL (18.6% vs 9.9%), (Table 1) . ACL occurred more on head and neck area (41.5%) followed by distal parts of limbs (29.2% in forearms and legs). However ACL lesions presented mainly on head and neck region while CCL lesions were on distal limbs (Table 2) . Truncal lesions were more likely to be atypical lesions as compared to lesions developed on other sites (22.8%, 16/70), (Table 1 ). Higher proportion of ACL lesions was irregular in shape as compared to classical lesion stages (41.2% vs 8.5%). Nearly 40% of ACL became irregular in shape at an early stage and this proportion did not increase over time (Table 3) .
. . Progress of Lesions. Multiplication and enlargement was shown in both early and late categories (Table 3 ). In early ACL lesions 53% were small (<2cm), while 20 % were large (>4cm). In chronic atypical lesions nearly equal proportions of both small and larger lesions were seen (Table 3) . Lesions became more irregular in shape with increasing lesion duration (Table 3) . Figure ) . Even though CCL was mainly observed in all the regions, geographical distribution pattern of ACL was significantly different from that of CCL (Table 4) . More than a third of lesions reported in less prevalent leishmanial areas (other regions) were ACL while North and South has lesser proportions of ACL (P<0.05), (Table 4) . North reported more ACL than South ( was clearly higher than proportion of ACL in residents of North (60.9% vs 15.9% in Table 4 ). Similarly, proportion of ACL in patients travelled from other regions to South was also higher than that of residents in South (42.9% vs 7.4% in Table 4 ). Rest of the group travelled only in areas within the same resident region also reported higher proportions of ACL as compared to that of total patient population in the region (57.9%, 32.8% in Table 4 ).
. . Geographical Distribution, Resident, and Visiting Populations (Table and
Rest of the group with a significant travel history (46/95) originated from either Northern or Southern regions in Sri Lanka. However, they had ACL lesion proportions consistent with the ACL proportions observed for the resident region, irrespective of their travel area (travel data not shown).
. . Treatment Response. An average of 18 doses of weekly or daily SSG and 16.7 months were taken by the patients with ACL to achieve a complete clinical cure of the lesions while average 10 doses over 12 weeks required for a CCL to complete clinical cure as evidenced by epithelialization. Three ACL lesions were on treatment at the time of analysis and remained inconclusive. (Figure ) . Detailed clinical observations of some individual cases of atypical CL are given below. An adult male (41 years) from Western region reported an irregular plaque that started with an atypical onset (a rash) on the earlobe. During the first 18 months the lesion developed in to a hyper-pigmented irregular plaque of approximately 5 cm in largest diameter. Surface scaling of lesion was observed. There was no sporotrichoid spread or clinical features suggestive of visceralization. Patient did not report a travel history to other regions He was in the same region during the preceding two years, in Central region, prior to that and had annual visits to Northern region for past 8 years. He was treated with 42 doses of IM-SSG, 13 doses of IL-SSG, and 2 doses of cryotherapy for 8 months. The lesion poorly responded to treatment and after 22 months of posttreatment, an exacerbation of the lesion was seen. Patient is still under treatment.
. . Different Presentations in Some Patients
An elderly male from Southern region presented with irregular erythematous ulcerative patches on head and neck region (Figure 4(b) ). Lesion started as a macule of approximately 5 cm in diameter. The ulcer showed well-demarcated (Figures 4(c) and 4(d) ). She worked in Batticaloa in Eastern region 8 months prior to lesion onset. Patient had a typical classical primary lesion which enlarged acutely to a size of approximate 8 cm in diameter. Lesions were erythematous and had well-defined margins with irregular edges. Both lesions had scaly surfaces. Surrounding skins showed inflammation, scaling, and no satellite lesions or sporotrichoid spread. On examination, she had no symptoms associated with visceral disease. A clinical cure was achieved with 6 intralesional doses of sodium stibo gluconate. 
Discussion
Clear majority of skin infections resulted in CCL over the past several years in this setting [14, 17, [19] [20] [21] . Meanwhile approximately a tenth of skin infections developed into ACL and further showed deviations from CCL. Most clinically straight forward lesions are either treated on clinical grounds or investigated in the hospital setting with the University center's establishment of microscopy training for government technical staff in health care institutions. An increasing trend to refer only nonclassical lesions to the specialized central laboratory was observed as a result during the latter part of the epidemic. Therefore, observed ACL prevalence is likely to be a slight exaggeration of the true figure, though these numbers were minimal and did not probably altered the overall figures considerably. ACL is of concern when changing trends within the CCL profile, poor treatment response, growing numbers of CL, emergence of VL, and presence of a genetic variant of a dangerous parasite are considered.
Age and gender association in ACL were consistent with previous findings for CCL in the country [20] . Zosteriform, sporotrichoid, acne-form generalized, erysepeloid, or plaque type lesions were observed within the ACL group.
Even though most ACL lesions started a classical primary lesion some reported a range of non-classical initial lesions including generalized body rashes, multiple acneform papules, or hypopigmented macular lesions. These lesions are likely to be misdiagnosed at the onset. Non classical onset also indicated high possibility for development of ACL later on. Atypical lesions were shown to develop both during early and late stages of the course of a lesion and associated with a poor laboratory confirmation rate. This indicates the low clinical screening power leading to referral of nonleishmanial cases, low parasitaemias, or both. Broad clinical picture of ACL was also different from that of CCL. Most remained nonulcerative and irregular in shape. Lesions that occur on back, trunk, head, and neck areas may have a tendency to develop in to ACL, a phenomenon observed in other settings as well [40] . Accurate detection of these is important as the general accepted norm is to suspect CL in rounded or oval shaped single lesions developing from classical primary lesions over exposed and peripheral body areas. ACL lesions tend to run a chronic course and/or self-referred later on to clinical setting as compared to CCL.
FGT is a crude test used to exclude VL. Parasitological assays used in leishmaniasis confirm infection in a given site while serology provides indirect evidence. But complete differentiation of VL from CL is difficult. Combination of clinical and laboratory results is usually considered in arriving at a diagnosis of either VL or CL. Skin lesion with evidence for parasites in the absence of systemic clinical features are treated as CL. Cases with systemic clinical features with parasite positivity in suitable internal tissue or indirect serological evidence are treated as VL. There can be a theoretical possibility of ACL in Sri Lanka to visceralize concurrently or subsequently, though this needs in depth studies to arrive at a conclusion. However, previous clinical studies have failed to demonstrate Visceralization of CL in this focus.
A proportion of ACL lesions remained small and single while the rest multiplied and enlarged as irregular shaped lesions during early or late stages during lesion development.
Local CL infection could be assumed to be confined to skin as previously reported [44] . Diagnostic clinical markers were previously developed for CL based on this assumption [35] . Presence of enlarged, irregular, and multiplied atypical lesions in some patients in both early and late durations may indicate possible individual variation in ACL progression.
At present, two main disease reporting areas are observed in Southern and Northern regions in the country [20] . But both CCL and ACL lesions were reported from diverse localities within the island. However, proportion of ACL occurring in other regions is clearly higher as compared to that of North and South. Northern focus seems to report more ACL as compared to South probably indicating a geographical variation of circulating parasite strains. Also proportion of ACL in resident CL patients of other regions travelled to North and South seems to be higher as compared to that of resident CL patients from North or South who probably acquired the infection within the resident area though they had a significant travel history to other districts or regions.
It may be assumed that the residents in other regions are nonimmune or less immune to leishmanial infections. Such individuals acquiring the infection while travelling in disease prevalent areas may be more likely to develop atypical lesions than the patients acquiring infections in immune populations. This may indicate a role of host immune mechanisms in clinical outcome. Final observed outcome may be the result of a possible combined role of the nonimmune host developing more ACL and geographical variations in circulating parasite strains with a slight influence from the different case referral patterns practiced by the clinicians. Regional variation in epidemiological characteristics is already known in this setting [21, 22] . Though it is not the focus of this publication, this may be worth the attention. Final clinical outcome, longterm sequalae, drug response patterns, and therefore the desired disease control methods may also be different in these two areas within the country.
Study also revealed that a considerable proportion of cases residing in other regions acquire leishmaniasis without a travel history to North or South. Circulating parasite variants in less leishmaniasis prevalent areas may result in establishment of infection in these areas further complicating clinical judgments and disease control.
Atypical lesions seem to demonstrate delayed response to the first line antileishmanial treatment as shown in some other studies as well [40, 45] . This provides further supportive evidence for the possible strain differences between the Leishmania sp. causing ACL or CCL in this endemic setting. Geographical location of the patient, likely place of acquiring infection, nature of primary lesion, and affected body site, seems to play a role in eventual development of a lesion in to ACL.
Conclusions
Current analysis demonstrated that dermotropic variants of local L. donovani infecting humans results in a variety of atypical lesions in a minority of infections and detailed the clinical profile and treatment outcome of this clinical entity for the first time. Underlying host or parasitic etiologies and ACL associated poor treatment response can further complicate the situation. This clinical entity thus deserves careful attention of the clinician, epidemiologist, and the researcher. Curative sector needs measures to encourage early referrals, better professional awareness, high degree of clinical suspicion, and adopting more sensitive diagnostic tools before arriving at a negative conclusion especially in less leishmanial prevalent areas [41] . Recently developed modified single tube nested PCR method may be used for disease confirmation in microscopically negative ACL [45] . Unknown sequalae associated with ACL can further complicate disease combatting efforts in an endemic setting. Parasite strain association and a role of host factors or both could be underlying etiologies of which understanding will facilitate appropriate handling of this clinical entity. Study of demographics, clinic, immunological, and parasitological factors in Northern and Southern leishmaniasis transmission foci are indicated.
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